{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:15:30Z","timestamp":1770282930594,"version":"3.49.0"},"reference-count":87,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01822"],"award-info":[{"award-number":["2020-01822"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Big Data &amp; Society"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p> How corporations surveil and influence consumers using big data tools is a major area of research and public debate. However, few studies explore it in relation to physicians in the USA, even though they have been surveilled and targeted by the pharmaceutical industry since at least the 1950s. Indeed, in 2010, concerns about the pharmaceutical industry's undue influence led to the passing of the Physician Sunshine Act, a unique piece of transparency legislation that requires companies to report their financial ties to physicians and teaching hospitals in a public database. This article argues that while the Sunshine Act has clearly helped expose important commercial influences on both prescribing and the scale of industry involvement with physicians, it has also, paradoxically, fuelled further commercial surveillance and marketing. The article casts new light on innovative pharmaceutical marketing approaches and the key role of data brokers and analytics companies in the identification, targeting, managing, and surveillance of physicians. We place this analysis within the political economies of the pharmaceutical industry, surveillance-based marketing, and transparency, and argue that policies to promote increased transparency must be tightly tied to policies that impede the commodification and use of transparency data for surveillance and marketing purposes. <\/jats:p>","DOI":"10.1177\/20539517211069631","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T16:08:18Z","timestamp":1644422898000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Capitalizing on transparency: Commercial surveillance and pharmaceutical marketing after the Physician Sunshine Act"],"prefix":"10.1177","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8773-9796","authenticated-orcid":false,"given":"Shai","family":"Mulinari","sequence":"first","affiliation":[{"name":"Department of Sociology, Faculty of Social Sciences, Lund University, Lund, Sweden"}]},{"given":"Piotr","family":"Ozieranski","sequence":"additional","affiliation":[{"name":"Department of Social and Policy Sciences, University of Bath, Bath, UK"}]}],"member":"179","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"bibr1-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2008.01101.x"},{"key":"bibr2-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1509103"},{"key":"bibr3-20539517211069631","author":"Anand R","year":"2017","journal-title":"Journal of the Pharmaceutical Management Science Association"},{"key":"bibr4-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199576746.003.0013"},{"key":"bibr5-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-32001-4_163-1"},{"issue":"4","key":"bibr6-20539517211069631","first-page":"456","volume":"1","author":"Arvidsson A","year":"2003","journal-title":"Surveillance & Society"},{"key":"bibr7-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.16036"},{"key":"bibr8-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/2053951720925853"},{"key":"bibr9-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1016\/j.giq.2014.02.009"},{"key":"bibr10-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/0038038506062034"},{"key":"bibr11-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113096"},{"key":"bibr12-20539517211069631","unstructured":"Chressanthis G, Padbidri G (2019) Axtria: Perspectives on pharma company use of open payments data. Available at: https:\/\/insights.axtria.com\/whitepaper-perspectives-on-pharma-company-use-of-open-payments-data (accessed 2 November 2021)."},{"key":"bibr13-20539517211069631","unstructured":"CMS (2021a) Data overview 2019. Available at: https:\/\/www.cms.gov\/OpenPayments\/Data (accessed 2 November 2021)."},{"key":"bibr14-20539517211069631","unstructured":"CMS (2021b) Newly added covered recipients. Available at: https:\/\/www.cms.gov\/OpenPayments\/Program-Participants\/Newly-Added-Covered-Recipients (accessed 2 November 2021)."},{"key":"bibr15-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/1461444816657096"},{"key":"bibr16-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/2053951720904112"},{"key":"bibr17-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1057\/9781137349477"},{"key":"bibr18-20539517211069631","unstructured":"Department of Justice (2012) GlaxoSmithKline to plead guilty and pay $3 billion to resolve fraud allegations and failure to report safety data. Available at: https:\/\/www.justice.gov\/opa\/pr\/glaxosmithkline-plead-guilty-and-pay-3-billion-resolve-fraud-allegations-and-failure-report (accessed 2 November 2021)."},{"key":"bibr19-20539517211069631","unstructured":"Department of Justice (2016) Former pharmaceutical company employees arrested for participating in fentanyl kickback scheme. Available at: https:\/\/www.justice.gov\/usao-sdny\/pr\/former-pharmaceutical-company-employees-arrested-participating-fentanyl-kickback-scheme (accessed 2 November 2021)."},{"key":"bibr20-20539517211069631","unstructured":"District Court of Massachusetts (2012) US complaint (CA No. 11-10398-RWZ). Available at: https:\/\/www.justice.gov\/sites\/default\/files\/opa\/legacy\/2012\/07\/02\/us-complaint.pdf (accessed 2 November 2021)."},{"key":"bibr21-20539517211069631","unstructured":"Doceree (2021) Doceree. Available at: https:\/\/doceree.com (accessed 2 November 2021)."},{"key":"bibr22-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1215\/9780822393481"},{"key":"bibr23-20539517211069631","volume-title":"Conflict of Interest in Medical Research, Education, and Practice","author":"Field MJ","year":"2009"},{"key":"bibr24-20539517211069631","doi-asserted-by":"publisher","DOI":"10.3138\/9781487529055"},{"key":"bibr25-20539517211069631","doi-asserted-by":"publisher","DOI":"10.36019\/9780813545936"},{"issue":"1","key":"bibr26-20539517211069631","first-page":"9","volume":"15","author":"Fourcade M","year":"2017","journal-title":"Socio-Economic Review"},{"key":"bibr27-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1186\/1747-5341-9-7"},{"key":"bibr28-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0630-0"},{"key":"bibr29-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050001"},{"key":"bibr30-20539517211069631","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-10-200705150-00008"},{"key":"bibr31-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2018.03.015"},{"key":"bibr32-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.6007"},{"key":"bibr33-20539517211069631","first-page":"789","volume":"11","author":"Heesters M","year":"2008","journal-title":"University of Pennsylvania Journal of Business Law"},{"key":"bibr34-20539517211069631","unstructured":"Hunkler RJ, Musacchio RA (2006) More than a game of keep away. Pharmaceutical executive 05-01-2006. Available at: https:\/\/www.pharmexec.com\/view\/more-game-keep-away (accessed 2 November 2021)."},{"key":"bibr35-20539517211069631","unstructured":"IMS Health (2007) Annual report for 2006. Available at: https:\/\/sec.report\/Document\/0001104659-07-013890\/ (accessed 2 November 2021)."},{"key":"bibr36-20539517211069631","unstructured":"IMS Health (2014) Prospectus for 2012. Available at: https:\/\/www.documentcloud.org\/documents\/1003681-ims-health-s-1.html (accessed 2 November 2021)."},{"key":"bibr37-20539517211069631","unstructured":"Jones D, Bang J, Zakrzewski S (2019) IQVIA insights leverage CMS data for strategy development. IQVIA. Available at: https:\/\/www.iqvia.com\/locations\/united-states\/library\/white-papers\/iqvia-insights-leverage-cms-data-for-strategy-development (accessed 2 November 2021)."},{"key":"bibr38-20539517211069631","volume-title":"Data mining at IMS health: How we turned a mountain of data into a few information-rich molehills","author":"Kallukaran P","year":"1999"},{"key":"bibr39-20539517211069631","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304946"},{"key":"bibr40-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024020"},{"key":"bibr41-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000431"},{"key":"bibr42-20539517211069631","first-page":"1361","volume":"65","author":"Kwoka MB","year":"2015","journal-title":"Duke Law Journal"},{"key":"bibr43-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06657-0"},{"key":"bibr44-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2009.09.002"},{"key":"bibr45-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1111\/jlme.12068"},{"key":"bibr46-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1215\/03616878-8893571"},{"key":"bibr47-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.154"},{"key":"bibr48-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-4446.2012.01424.x"},{"key":"bibr49-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12317-z"},{"key":"bibr50-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMhle1107678"},{"key":"bibr51-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/0306312718772086"},{"key":"bibr52-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/0306312705052103"},{"key":"bibr53-20539517211069631","doi-asserted-by":"publisher","DOI":"10.7326\/M20-5665"},{"key":"bibr54-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2015.06.020"},{"key":"bibr55-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1111\/soc4.12335"},{"key":"bibr56-20539517211069631","unstructured":"Ornstein C (2014) Big Data+Big Pharma=Big Money. ProPublica, January 10. Available at: https:\/\/www.propublica.org\/article\/big-data-big-pharma-big-money (accessed 2 November 2021)."},{"key":"bibr57-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2613"},{"key":"bibr58-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1806"},{"key":"bibr59-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053138"},{"key":"bibr60-20539517211069631","unstructured":"PhRMA (2020) Code on interactions with health care professionals. Available at: https:\/\/www.phrma.org\/Codes-and-guidelines\/Code-on-Interactions-with-Health-Care-Professionals (accessed 2 November 2021)."},{"issue":"100","key":"bibr61-20539517211069631","first-page":"100","volume":"128","author":"Pozen DE","year":"2018","journal-title":"The Yale Law Journal"},{"key":"bibr62-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199576746.003.0006"},{"key":"bibr63-20539517211069631","doi-asserted-by":"publisher","DOI":"10.24908\/ss.v8i3.4163"},{"key":"bibr64-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1353\/bhm.2014.0075"},{"key":"bibr65-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1111\/jlme.12078"},{"key":"bibr66-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/2053951718820549"},{"key":"bibr67-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040286"},{"key":"bibr68-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/0270467611422838"},{"key":"bibr69-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1111\/jlme.12073"},{"key":"bibr70-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150032"},{"key":"bibr71-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-024-0979-6_4"},{"key":"bibr72-20539517211069631","volume-title":"Platform Capitalism","author":"Srnicek N","year":"2017"},{"key":"bibr73-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068125"},{"key":"bibr74-20539517211069631","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-4-200608150-00008"},{"key":"bibr75-20539517211069631","unstructured":"Sturgis M (2017) ZS: Doctors to pharma: \u2018Let\u2019s get personalized\u2019: How to deliver high-quality messaging that\u2019s tailored to physician preferences. ZS. Available at: https:\/\/www.zs.com\/insights\/doctors-to-pharma-lets-get-personalized (accessed 2 November 2021)."},{"key":"bibr76-20539517211069631","unstructured":"Sullivan T (2019) Open payments for all \u2013 Cresen solutions launches PowerCMS\u2122. Policy & Medicine, June 28. Available at: https:\/\/www.policymed.com\/2019\/06\/open-payments-for-all-cresen-solutions-launches-powercms.html (accessed 2 November 2021)."},{"key":"bibr77-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001270"},{"key":"bibr78-20539517211069631","unstructured":"Transparence-Sant\u00e9 (2017) Licence de r\u00e9utilisation de l\u2019information. Available at: https:\/\/www.data.gouv.fr\/fr\/datasets\/transparence-sante-1\/ (accessed 2 November 2021)."},{"key":"bibr79-20539517211069631","author":"Tsang JP","year":"2018","journal-title":"Journal of the Pharmaceutical Management Science Association"},{"key":"bibr80-20539517211069631","doi-asserted-by":"publisher","DOI":"10.24908\/ss.v12i2.4776"},{"key":"bibr81-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001945"},{"key":"bibr82-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1177\/0007650317718185"},{"key":"bibr83-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2008.01123.x"},{"key":"bibr84-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06802-9"},{"key":"bibr85-20539517211069631","unstructured":"Yuan Y, Zhao E (2018) IQVIA: Leveraging artificial intelligence and machine learning to drive commercial success. IQVIA. Available at: https:\/\/www.iqvia.com\/library\/white-papers\/leveraging-artificial-intelligence-and-machine-learning-to-drive-commercial-success (accessed 2 November 2021)."},{"key":"bibr86-20539517211069631","unstructured":"Yuan Y, Wartenberg F, Wolk A, et al. (2019) IQVIA: Using AI & machine learning to drive commercial success in the EU. IQVIA. Available at: https:\/\/www.iqvia.com\/library\/white-papers\/using-ai-and-machine-learning-to-drive-commercial-success-in-the-eu (accessed 2 November 2021)."},{"key":"bibr87-20539517211069631","doi-asserted-by":"publisher","DOI":"10.1057\/jit.2015.5"}],"container-title":["Big Data &amp; Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20539517211069631","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20539517211069631","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20539517211069631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T17:57:14Z","timestamp":1740938234000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20539517211069631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1177\/20539517211069631"],"URL":"https:\/\/doi.org\/10.1177\/20539517211069631","relation":{},"ISSN":["2053-9517","2053-9517"],"issn-type":[{"value":"2053-9517","type":"print"},{"value":"2053-9517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"20539517211069631"}}